Tool offers increased precision in estimating exacerbation risk Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality worldwide. It is frequently seen in primary ...

Singing and playing the ukulele reduces anxiety and boosts relaxation, the Sheffield hospice says.

Enanta Pharmaceuticals (NASDAQ:ENTA) used a presentation at the Citizens Life Sciences Conference to outline its evolving ...

As the UK National Screening Committee (UK NSC) reviews chronic obstructive pulmonary disease (COPD) screening, there is an opportunity to move ...

Presentations highlight real‑world dosing and titration patterns in youth, and post‑prandial glucose management strategies using inhaled insulin ...

Record CyPath® Lung Revenue and Unit Sales. Revenue from our noninvasive diagnostic for lung cancer increased 87% over 2024 with the number of tests performed rising 99% year over year, reflecting ...

(NYSE: PFE) today announced positive topline results from a Phase 2 study investigating tilrekimig (PF-07275315) in adults with moderate to severe atopic dermatitis. The study met its primary efficacy ...

A little-known virus that causes nasty flu-like symptoms is spreading in California — and it doesn’t have a vaccine. Cases of human metapneumovirus (HMPV) have been steadily rising since winter began, ...

Antioxidants are widely promoted as beneficial for health, but emerging research suggests that excessive intake may have unintended consequences.

TSANZSRS Annual Scientific Meeting 2026 in Perth to address key respiratory health priorities, including environmental threats, AI ...

Pfizer said a Phase 2 study of tilrekimig met its key goals in adults with moderate to severe atopic dermatitis, the most common form of eczema, and that it plans to accelerate the drug candidate into ...

TrumpRx aims to lower drug prices in the U.S. by matching the lowest prices charged in other developed countries.